Atlas Trials

Arteriosclerosis Obliterans

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Arteriosclerosis Obliterans

RecordFirmDate
A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans (NCT02877173)Guangzhou Yipinhong Pharmaceutical CO.,LTD2016-08-01
Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia (NCT02864654)Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation2016-07-01
Arterial Calcification in the Diabetes (NCT02431234)Assistance Publique - Hôpitaux de Paris2014-02-01
HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F) (NCT01518205)Universita di Verona2012-02-01
Sufficient Treatment of Peripheral Intervention by Cilostazol (NCT00912756)Kansai Rosai Hospital2009-03-01
Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages (NCT00712946)GE Healthcare2006-03-01
TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation (NCT00145262)Nagoya University2003-08-01

Track Arteriosclerosis Obliterans automatically

Every clearance here is in the API, with alerts when new ones post.